warning

Alert: Because flu cases are on the rise, children 12 and younger will be restricted from visiting hospitals and certain inpatient facilities. Learn more.

Research and Clinical Trials

Title  
LCI-HEM-PCD-SPEC-001: Biospecimen Acquisition for Analysis of Plasma Cell Disorders
Brief Description  
Primary: To collect high quality biospecimens to study plasma cell disorders. Exploratory: 1. To determine the differences between precurser states and multiple myeloma using gene expression data, DNA sequencing, RNA studies, epigenetics, proteomics, metabolomics, pathway analysis, and immunophenotypic analysis. 2. To standardize MRD assays and validate prognostic MRD thesholds for MRD monitoring as a tool for risk-adapted clinical trials. 3. To evaluate biomarkers and immune markers associated
Who may be Eligible  
Please contact us for eligibility criteria.
Speciality/Disorder  
Other Hematopoietic
Status  
OPEN
Start Date  
09/28/2015
IRB Number  
00012941
Principal Investigator  
Bhutani, Manisha
Contact Name  
Mitchell Turner

For More Information, Contact  Mitchell  , Turner
Phone:  980-446-5248 Fax:    
Email:  Mitchell.Turner@carolinashealthcare.org
Address: ,
Close